A panel of experts that advises the Centers for Disease Control and Prevention on vaccine policy will not meet as previously ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
Northstrive Biosciences has submitted a pre-Investigational New Drug, or pre-IND, meeting request to the FDA for EL-22, a novel myostatin asset ...
Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...
The Food and Drug Administration (FDA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) met on Tuesday to optimize the facilitated review pathway (FRP) to expedite access to essential ...
WASHINGTON (AP) — The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug ...
A CDC vaccine advisory committee meeting scheduled for next week has been postponed. It was the first vaccine meeting since ...
As the company prepares for its regulatory meetings, the healthcare community ... OST-HER2 osteosarcoma trial payments and prepare for FDA approval. Additionally, OS Therapies has acquired ...
Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute graft-versus-host disease (SR-aGvHD) in pediatric patients 2 months ...
As the company prepares for its regulatory meetings, the healthcare community and investors ... it to finalize its OST-HER2 osteosarcoma trial payments and prepare for FDA approval. Additionally, OS ...